Dr. D.'s Overhead Lecture Notes
Section 4 - REPLACE PAGE NUMBERS WITH PAGES FROM SIXTH EDITION4
Do Not Print This Page
These notes are in your course booklet and in Sec 04-w.htm.
Page index for Sec04
Kidney Functions
Kidney Operations
Kidney Regulation
1. Renin-angiotensin
mechanism
2. ADH
mechanism
Renal Failure
-
stages
-
types
Glomerulonephritis
Acute poststreptococcal
glomerulonephritis (APSGN)
Rapidly progressive glomerulonephritis
Chronic glomerulonephritis
Pyelonephritis
Acute pyelonephritis
Chronic pyelonephritis
Hypertensive Kidney
Polycystic Kidney
Hydronephrosis
Nephrotic Syndrome
End stage kidney
Uremic Syndrome
Chemical
imbalances
Consequences
Treatment
strategies
Acute Renal Failure
Causes
Pathogenesis
Consequences
Treatment
strategies
Endocrine System Notes
1. Treatment strategies
Diabetes mellitus
1. Major types of diabetes mellitus
2. Contributing factors
A. Effects of high blood
glucose
1. Kidney tubules
2. Blood vessels
3. Blood
4. Connective tissue
5. Nervous system
6. Eyes
7. Bacteria
B. Effects of high ketoacids
Treatment Goals
Treatment Strategies
Kidney Functions - for homeostasis (p. 659)
1.
Normal adult kidney, gross
2.
Normal adult kidney, cross section, gross [IVP]
84.
Normal glomerulus, microscopic *
1. regulate blood osmotic pressure
(2.85mOsm)
2. regulate concentration of each
mineral salt
3. regulate pH (7.35 - 7.45)
4. regulate blood pressure
5. eliminate nitrogen wastes
6. regulate RBC production
7. activate vitamin D
Kidney Operations and urine formation - for functions 1-5 above
1. filtration (pp.
657, 658, 662)(sketch)
- in
glomerulus
- separates
small molecules from large molecules and cells -> filtrate
2. reabsorption (pp.
657, 662, 667)(sketch)
- PCT
(proximal convoluted tubule)
- bulk reabsorption
- not much regulation (some by aldosterone)
- loop
of Henle
- Na+ (sodium ions)
- not regulated
- DCT
(distal convoluted tubule)
- small amount reabsorbed
- well regulated (by aldosterone)
- collecting
duct
- water
- well regulated (by ADH)
3. secretion (pp.
657, 662, 667)(sketch)
- PCT,
DCT, and collecting duct
- H+, N, K+, PO-3, uric acid, others
1. Renin-angiotensin mechanism (p. 671)
With decr.
BP (sketch)
|
incr. angiotensin |
|
| yields yields | |
| systemic vasoconstriction | incr.aldosterone
(from adrenal cortex) |
| yields | yields |
| incr. Na+ and H2O reabsorption | |
| yields | |
| incr. blood volume | |
| yields | |
| incr. BP (homeostasis) | |
With incr. BP (sketch)
incr.
BP or other changes in filtrate Na+ conc. -> decr.
renin ->
opposite effects (i.e., vasodilation,
decr.
aldosterone)
yields
decr.
BP -> homeostasis
With decr.
BP(sketch)
| decr. BP or incr. osmotic pressure (high salt conc.) -> + hypothalamus | |
| yields yields | |
| incr. ADH (from pituitary) | incr. thirst |
| yields | yields |
| incr. H2O reabsorption by collecting duct | incr. drinking |
| yields | |
| incr. BP and decr. osmotic pressure (homeostasis) | |
With incr. BP(sketch)
acute renal
failure
chronic renal
failure
- may start in glomeruli, tubules, or vessels
- all parts finally damaged ->
- end stage kidney (ESK) (structural) (p.
706)
43.
End stage renal disease, gross
44.
End stage renal disease, microscopic *
- renal failure (inadequate function) (pp.
692, 724)
- uremic syndrome (certain S&S) (p.
724)
- stages based on % nephrons and presence of S&S
- decreased renal reserve
- 1%-75% of nephrons gone = 99%-25% of nephrons left
- S&S only under stress conditions
- renal insufficiency
- 75%-90% of nephrons gone = 25%-10% of nephrons left
- S&S always present
- renal failure ( = end stage kidney = uremic
syndrome)
- 90%-100% of nephrons gone = 10%-0% of nephrons left
- severe S&S (uremic syndrome) and loss of homeostasis
- glomerulonephritis = (glomeruli affected first)
84.
Normal glomerulus, microscopic *
- pyelonephritis = (tubules affected first)
- hypertensive kidney = 5% of cases (vessels affected first)
- polycystic kidney = 5% of cases (all parts affected) (p.
712)
- other causes
(1) diabetes mellitus (p. 714)
(2) renal artery stenosis (pp. 687,
710)
(3) systemic connective tissue autoimmune diseases (p.
711)
(4) toxins (phenacetin, lead, certain medications, etc.)
Acute poststreptococcal glomerulonephritis (APSGN) (p. 704)
causes
infection someplace other than the urinary system
pathogenesis
84.
Normal glomerulus, microscopic *
41.
Nodular glomerulosclerosis, microscopic *
42.
Nodular glomerulosclerosis and hyaline arteriolosclerosis, microscopic,
PAS stain *
88.
Focal segmental glomerulosclerosis (FSGS), microscopic *
89.
Focal segmental glomerulosclerosis (FSGS), microscopic, Trichrome stain
*
90.
Post-streptococcal glomerulonephritis, low power microscopic
*
91.
Post-streptococcal glomerulonephritis, high power microscopic
*
92.
Post-streptococcal glomerulonephritis, granular immune deposits, immunofluorescence
microscopy *
93.
Post-streptococcal glomerulonephritis, electron micrograph *
94.
Membranous glomerulonephritis, microscopic *
(sketch)
|
|
|||
|
|
|||
|
(pp. 159, 703) -> |
|
|
|
|
|
|||
| incr. renin (p. 671) -> incr. H2O retention | |||
|
|
|||
| incr.incr. oliguria, incr. incr. edema, incr. incr. BP | |||
| (2) inflamed
glomeruli
(pp. 159, 703)
-> large pores -> protein leakage ->
|
|||
NOTE: edema from
1. decr.
GFR
2. renin mechanism
- 85% cases resolve, some cases -> permanent damage, 2%-5% cases -> ESK
Rapidly progressive glomerulonephritis (RPGN) (p. 705)
causes
autoimmiune
attack on kidneys
pathogenesis
98.
Rapidly progressive glomerulonephritis with crescents, microscopic
*
99.
Rapidly progressive glomerulonephritis with crescents, microscopic
*
100.
Rapidly progressive glomerulonephritis with crescents, fluorescence microscopy
*
autoimmune attack on glomeruli
-> like CGN ->
ESK in 3 mo. - 2 yrs.
Chronic glomerulonephritis (CGN) 2-40 years to reach ESK (p. 705)
pathogenesis(sketch)
|
|
|||
| (1) clogged glomeruli -> like APSGN with renin -> incr. incr. edema etc. | |||
| (2) very inflamed glomeruli -> very large pores -> incr. incr.. protein leakage (p. 708) (nephrotic syndrome) -> decr. COP -> (a) decr. fluid return & (b) hyperlipidemia | |||
|
|
|||
| a. -> incr. incr. incr. edema | |||
| a. -> decr. blood volume -> incr. ADH (p. 670) -> incr. incr. H2O retention -> incr. incr. incr. incr. edema (not incr. BP) | |||
|
|
|||
| b. -> atherosclerosis -> more kidney problems |
finally
-> tubule and vessel damage -> ESK, renal failure, uremic syndrome
44.
End stage renal disease, microscopic *
NOTE: edema from
1. decr.
GFR
2. renin mechanism
3. decr.
COP
4. ADH mechanism
Acute
pyelonephritis
causes
infection
in kidney, toxins
pathogenesis(sketch)
infection in kidney or toxins -> injured and inflamed tubules (p.699c) -> decr. amount and decr. control of reabsorption and secretion -> decr. homeostasis (osmotic pressure, conc. of salts, pH, BP)
infection from
blocked urine flow from -
- strictures(sketch)
- calculi (sketch)
1.Synovial
fluid with sodium urate crystals, polarized light with red compensator,
microscopic. *
7.
GIF animation of urinary tract lithiasis
- neoplasms (sketch)
- prostatic hypertrophy (sketch)
18.
Bladder hypertrophy and calculus with obstruction from nodular hyperplasia
of prostate, gross
- neurogenic bladder
introduction from -
- sexual activity (especially from shorter urethra in women)
- cystoscopy
- catheters
decr.
resistance from -
- stress
refluxing from -
- faulty ureter/bladder connection (sketch)
systemic S&S
(leucocytosis, fever, chills, back pain, voiding pain)
urine S&S
(polyuria, proteinuria, bacteria, pyuria, casts (pp.
684, 700), WBCs)
Chronic pyelonephritis (p. 700)
causes
chronic infection
in kidneys, chronic toxins
pathogenesis
infection in
kidney, chronic toxins -> chronic tubule inflammation
-> injured and scarred tubules (p. 706)
-> decr.
amount and decr.
control of reabsorption and secretion -> decr.
homeostasis (osmotic pressure, conc. of salts, pH, BP)
- finally
-> glomeruli and vessel damage ->
ESK (p. 706)
renal failure
uremic syndrome
S&S =
polyuria
nocturia
low urine specific gravity (dilute urine) (p.
682)
dehydration (p. 682)
salt loss (p. 682)
incr. or decr.
pH (p. 683)
incr. renin (attempts to retain Na+
and H2O)
Hypertensive
Kidney
causes
high blood pressure
pathogenesis
37.
Benign nephrosclerosis, gross
38.
Malignant nephrosclerosis, gross
39.
Malignant nephrosclerosis with fibrinoid necrosis, microscopic
*
40.
Hyperplastic arteriolitis with hypertension, microscopic *
chronic incr.
BP
-> kidney vessel damage -> fibrosis -> ischemia ->
glomeruli and tubule damage ->
decr.
GFR -> incr.
renin -> incr.incr.
BP -> more vessel damage -> -> ->
ESK (p. 709)
renal failure
uremic syndrome
S&S =
incr. BP
proteinuria
hematuria
azotemia
Polycystic
Kidney (p. 712)
causes
genetic (inherited)
pathogenesis (sketch)
62.
Dominant polycystic kidney disease, gross
63.
Dominant polycystic kidney disease, gross
64.
Dominant polycystic kidney disease, gross [CT]
67.
Multiple simple renal cysts, gross
62.Dominant
polycystic kidney disease with polycystic liver, gross [CT]
62.
Dominant polycystic kidney disease with polycystic liver, gross [CT]
abnormal gene -> cyst formation -> damaged nephrons -> renal failure & uremic syndrome
Hydronephrosis
causes
chronic partial
urine obstruction, urine refluxing
pathogenesis (sketch)
(1) chronic partial
obstruction (stricture, calculi, neoplasms, prostatic hypertrophy, neurogenic
bladder) ->
or
(2) refluxing
->
urine retention -> pressure in kidney -> tubule and vessel damage
S&S = oliguria followed by polyuria, azotemia, acidosis, kidney atrophy
finally
-> glomerular damage ->
ESK
renal failure
uremic syndrome
calculi
1.Synovial
fluid with sodium urate crystals, polarized light with red compensator,
microscopic. *
7.
GIF animation of urinary tract lithiasis
10.
Hydronephrosis with calculus at ureteropelvic junction, gross
9.
Hydronephrosis, severe, gross [CT]
8.
Hydronephrosis from obstruction by calculus, gross
11.
Hydroureter and hydronephrosis, gross [XRAY]
prostatic hypertrophy
18.
Bladder hypertrophy and calculus with obstruction from nodular hyperplasia
of prostate, gross
S&S = oliguria followed
by polyuria, azotemia, acidosis, kidney atrophy
Nephrotic
Syndrome (p. 708)
causes
massive protein
loss in urine (severe proteinuria)
pathogenesis
| very inflamed glomeruli -> very large pores -> incr. incr. protein leakage (nephrotic syndrome) -> decr. COP (hypoalbumemia) -> (a) decr. fluid return & (b) hyperlipidemia (from liver metabolism) | |||
|
|
|||
| a. decr. COP -> 1. incr. incr. incr. EDEMA | |||
| a. decr. COP -> decr. fluid return -> decr. blood volume -> incr. ADH -> incr. incr. H2O retention -> incr. incr. incr. incr. edema & decr. BP -> (2, 3, & 4) | |||
| 2. decr. GFR -> H2O retention -> incr. incr. EDEMA | |||
| 3. incr. renin -> H2O retention -> incr. incr. EDEMA | |||
| 4. incr. ADH -> H2O retention -> incr. incr. EDEMA | |||
| b. hyperlipidemia -> atherosclerosis -> more kidney problems, etc. |
NOTE: edema from
1. decr.
GFR
2. renin mechanism
3. decr.
COP (occurs first)
4. ADH mechanism
End Stage Kidney (pp. 700, 706, 709, 714)
43.
End stage renal disease, gross
44.
End stage renal disease, microscopic *
- glomeruli
- solidified (hyalinized)
- tubules
- few, small, distorted
- vessels
- few, small, distorted
- much scar
tissue (fibrosis)
Chemical
imbalances
1. water (regulated and variable reabsorption)
- excess retention -> osmotic problems, incr.
BP, edema, CHF
- excess elimination -> osmotic problems, decr.
BP
- no regulation by kidney -> urine specific gravity of 1.010
= renal failure = ESK
2. sodium (regulated and variable reabsorbed
- most is reabsorbed)
- excess retention (common) -> edema, incr.
BP, CHF
- excess elimination (rare) -> nerve and muscle malfunction
3. potassium (regulated and variable
reabsorption and secretion)
- excess retention (usual) or elimination -> arrhythmias
4. pH (regulated and variable secretion)
- excess retention (usual) or elimination -> enzyme malfunction
-> cell malfunction, cell injury, cell death
5. nitrogen wastes (eliminated by filtration
- ex. urea, creatinine)
- excess retention -> toxicity -> cell injury/cell
death
6. uric acid (eliminated by filtration and
secretion)
- excess retention -> crystals -> inflammation
(ex. gout)
7. blood proteins (usually retained)
- excess loss (damaged glomeruli or tubules) ->
(1) casts -> blocked tubules and urine flow
(2) decr.
COP -> edema, nephrotic syndrome
Consequences(pp.
724,
727, 729, 731)
- multiple organ and system malfunctions
Treatment
strategies (p. 735)
1. substitute regulation
- conservative
a. regulate input (diet = foods and beverages)
b. regulate production (e.g., exercise)
c. regulate output (e.g., temperature, medications, exercise)
- extreme
d. dialysis (pp. 742, 744)
e. transplant (p. 746)
2. check for and treat complications (ex. infection, circulatory
problems, bone degeneration, gout)
Causes(p.
756)
1. ischemia (pre-renal)
2. toxins (tubular necrosis)
3. obstruction (post-renal)
1.
ischemia -> decr.
GFR -> (sketch)
oliguria
-> relief ->
recovery
(low GFR)
or yields
polyuria
-> relief ->
recovery
(damaged tubules)
or yields
renal failure (uremic syndrome)
2.
toxins -> tubule injury ->
32.
Acute tubular necrosis with ethylene glycol poisoning, microscopic*
oliguria
-> relief ->
recovery
(casts block)
or yields
polyuria ->
relief -> recovery
(damaged tubules)
or yields
renal failure (uremic syndrome)
3.
obstruction ->
oliguria ->
relief -> recovery
(partial obstruction)
or yields
polyuria ->
relief -> recovery
(damaged tubules)
or yields
renal failure (uremic syndrome)
Consequences(pp.
724)
- multiple organ and system malfunctions
Treatment
strategies (pp. 735, 742, 744, 746)
- same as for above for uremic syndrome
Endocrine
System Lecture Notes
Endocrine
System Lecture Notes
Chapter 58
1. Treatment strategies
- reduce hormone excesses (e.g., remove
part or all of endocrine gland)
- augment deficient hormone (e.g.,
administer hormone injections)
Chapter 63 - Diabetes mellitus = DM = a disease involving loss of ability to regulate blood glucose levels and resulting in a decrease in tolerance of carbohydrate input (i.e., glucose levels rise above normal)
Normal
islets of Langerhans, with immunoperoxidase stains (right, insulin and
left, glucagon), microscopic
Islet
of Langerhans, insulitis, microscopic
Islet
of Langerhans, deposition of amyloid, microscopic
1. Major types of diabetes mellitus
- Insulin dependent diabetes mellitus
= IDDM
- insulin
supplements required for survival
- also called
Type I diabetes mellitus
- also called
juvenile
onset (most cases develop during youth)
- also called
ketosis-prone
(most cases show high levels of ketones in the urine - ketones come from
fat breakdown)
- represents
5% - 10% of cases of DM
- Non-insulin dependent diabetes
mellitus = NIDDM
- survival
possible without insulin supplements
- also called
Type II diabetes mellitus
- also called
maturity
onset diabetes mellitus (most cases develop after age 40)
- also called
non-ketosis
prone (few cases show excess ketone levels in the urine)
- represent
90% - 95% of cases of DM
- other types are from other causes (e.g., pregnancy = gestational DM, pancreatitis or cancer or other disorders = secondary DM)
2. Contributing factors (a - g)
a. Genes, especially for NIDDM
- environmental
factors (e.g., virus, obesity) may trigger genes to decrease insulin production
b. Sedentary lifestyle
- low muscle
activity decreases sensitivity of muscle cells to insulin and therefore
more insulin is needed to get the same effect
(sketch)
c. Obesity, especially from
high carbohydrate diet
- obesity
decreases sensitivity of cells to insulin and therefore more insulin is
needed to get the same effect
(sketch)
d. Stress (e.g., infection,
emotions)
- stress ->
increase in glucocorticoids and norepinephrine, which antagonize insulin
and raise blood glucose levels
e. Pregnancy
- estrogen
antagonizes insulin
f. Autoimmune response
- autoimmune
attack on the pancreas destroys insulin-producing cells
- major cause
of IDDM
g. Medications
-various medications
antagonize insulin (e.g., corticosteroids used as anti-inflammatory agents)
3. Normal regulation of blood glucose
- pancreatic hormones
- main regulators
- insulin
- from beta cells in pancreas
- cause decr. blood glucose
- glucagon
- from alpha cells in pancreas
- causes incr. blood glucose
- other
hormones
- (e.g., norepinephrine, growth hormone, glucocorticoids, sex hormones,
etc.)
- maintain homeostasis of blood glucose
in spite of input (diet) and use (metabolism)
- normal
range = 70 - 120 mg% in blood
- mechanisms of normal control
- liver cells
(+ or -), fat cells (+ or -), and muscle cells (- only) are main cells
involved
Normal (sketch)
| incr. blood glucose -> |
incr. insulin &
->
decr. glucagon |
1. incr.
gluc. into cells
-> |
-> decr.
blood glucose
(homeostasis) |
| 2. incr. gluc.
stored
as
glycogen -> |
|||
| 3. incr.
gluc. stored as
fat -> |
|||
| 4. incr. gluc.
used
for
proteins -> |
OR
| decr. blood glucose -> |
decr. insulin &
->
incr. glucagon |
1. decr.
gluc. into cells
-> |
-> incr.
blood glucose
(homeostasis) |
| 2. gluc. made from
glycogen leaves cells -> |
|||
| 3. gluc. made from
fat leaves cells -> |
|||
| 4. decr. gluc.
used for
proteins -> |
(sketch)
(graph)
(cell)
Normally:
glucose + O2 -> CO2 + H2O + energy
fats + O2
-> (needs some glucose for reactions) ->
CO2 + H2O + energy
4. "Regulation" of blood glucose with diabetes mellitus (sketch)
|
incr.
blood glucose ->
|
"no" insulin &
->
incr. glucagon |
1. decr.
gluc. into cells
-> |
-> incr.incr.
blood glucose (not homeostasis) (still little glucose in pancreas cells) |
| 2. gluc. made from
glycogen leaves cells -> |
|||
| 3. gluc. made from
fat leaves cells -> |
|||
| 4. decr. gluc.
used for
proteins -> |
yields
|
"no" insulin & -> incr. incr. glucagon (still little glucose in pancreas cells) |
1. decr.
gluc. into cells
-> |
-> incr.
incr. blood glucose
(not homeostasis) (still little glucose in pancreas cells) |
| 2. gluc. made from
glycogen leaves cells -> |
||
| 3. gluc. made from
fat leaves cells -> |
||
| 4. decr. gluc.
used for
proteins -> |
yields
|
"no" insulin & -> incr.incr. incr. glucagon (still little glucose in pancreas cells) |
1. decr.
gluc. into cells
-> |
-> incr.incr.
incr. blood glucose
(NOT homeostasis) -> etc. (still little glucose in pancreas cells) |
| 2. gluc. made from
glycogen leaves cells -> |
||
| 3. gluc. made from
fat leaves cells -> |
||
| 4. decr. gluc.
used for
proteins -> |
(sketch) (graph)
(cell)
Note: incr.
blood glucose -> incr. incr. blood
glucose ->
incr. incr.incr.
blood glucose -> etc.
AND
with little glucose in cells for energy, cells try to use fats (& proteins) for energy
BUT
fats & proteins (with no glucose in cells) ->
ketones
(ketoacids) = ketosis (ketoacidosis)
SO
1. high blood glucose
AND in severe cases
2. high blood ketoacids (sketch)
Why is Diabetes Mellitus a Bad Idea?
A. Effects
of high blood glucose
1.
Kidney
tubules (regulate osmotic pressure, salts, BP) (sketch)
a. glycosuria -> energy loss -> polyphagia
(and weight loss when severe)
Renal
glomerulus, nodular glomerulosclerosis, microscopic
Renal
glomerulus, nodular glomerulosclerosis, hyaline arteriolosclerosis, PAS
stain, microscopic
b. polyuria -> (1, 2)
1. dehydration -> thirst -> polydipsia
2. osmotic problems, decr. BP (sketch)
c. salt loss -> salt imbalance -> malfunctions (sketch)
(e.g., heart, brain) -> coma, death
2. Blood vessels (glycoproteins)
a. capillaries
thick basement membranes -> (1, 2) (sketch)
1. decr. capillary exchange -> cell
malfunctions
2. clogged glomeruli -> decr. GFR ->
-> -> ESK
84.
Normal glomerulus, microscopic *
41.
Nodular glomerulosclerosis, microscopic *
42.
Nodular glomerulosclerosis and hyaline arteriolosclerosis, microscopic,
PAS stain *
b. arterioles
vessel wall injury -> kidney vessel damage -> -> ESK (like hypertensive
kidney)
42.
Nodular glomerulosclerosis and hyaline arteriolosclerosis, microscopic,
PAS stain *
c. arteries
atherosclerosis -> M.I.s, strokes, peripheral vascular disease -> poor
healing, infections, gangrene
Left
anterior descending coronary artery, advanced atherosclerosis, gross
Left
anterior descending coronary artery, recent thrombus, microscopic
Interventricular
septum, recent myocardial infarction, gross
Aortic
atherosclerosis demonstrated in three aortas, gross
Foot
with previous healed transmetatarsal amputation and recent ulcer, gross
Gangrenous
necrosis and ulceration, lower extremity, gross
3. Blood
(glycoproteins)
glycoproteins -> (a, b, & c)
a. thrombus formation -> ischemia -> cell injury
b. decr. O2 on Hb -> decr.
O2 supply -> cell injury
c. decr. WBC functioning -> incr.
infections
4. Connective
tissue (glycoproteins) (sketch)
linked fibers -> (a & b)
a. decr. diffusion -> decr. servicing of cells -> cell injury/cell death (ex. dermis)
b. stiffness -> difficulty moving
5.
Nervous
system (sorbitol)
sorbitol in neurons & myelin -> neuron malfunction -> decr. sensory
and motor functioning -> (a-d)
a. decr. sensations
b. decr. muscle strength -> increased
injury and infections
c. decr. muscle reflexes
d. decr. autonomic reflexes -> (1-3)
1. decr. sweating -> incr.
hyperthermia
2. abnormal G.I. peristalsis -> indigestion and maldigestion
3. fecal and urinary incontinence
in lens -> cataracts -> blindness
Normal
appearance, retina on funduscopic examination
Cataract
of the crystalline lens, gross
Cataract,
gross
in retina -> diabetic retinopathy -> blindness (sketch)
Diabetic
retinopathy on funduscopic examination
Proliferative
diabetic retinopathy on funduscopic examination
Glaucoma,
cupping of the optic disk on funduscopic examination
Glaucoma
with excavation of the optic cup, microscopic
incr.
glucose -> incr. bacterial growth ->
incr.
infections
Kidney,
acute pyelonephritis, microscopic
Renal
pelvis, infection with Candida albicans, PAS stain, microscopic
ketoacids -> (1, 2, & 3)
1. decr. pH (acidity) -> cell malfunction
(ex. brain -> coma, death)
2. salt loss in urine -> cell malfunction (sketch)
(ex. brain -> coma, death)
3. incr risk of infection
Nasopharynx,
mucormycosis (zygomycosis), H and E stain, microscopic
Treatment Goals
(1, 2, & 3)
1. maintain glucose homeostasis
2. prevent ketoacidosis
3. prevent complications
Treatment Strategies
(1 - 6)
1. substitute regulation
a. regulate input (diet = foods and beverages, CHOs) (regulates
glucose levels)
b. regulate use (e.g., exercise) (alters glucose use and insulin
sensitivity)
c. avoid obesity (alters insulin sensitivity)
d. insulin therapy (regulates glucose levels)
e. medications (regulate insulin production and glucose levels)
2. check
for and treat complications (e.g., see above)
Do Not Print This Page Print the Sec04-w.htm version only.
Do Not Print This Page Print
the Sec04-w.htm version only.
© Copyright 2002 - Augustine G. DiGiovanna - All rights reserved. All rights reserved. Except as permitted under the United states Copyright Act of 1976, no part of this page may be reproduced or distributed in any form or by any means, or stored in a data base or retrieval system, without the prior written permission of Augustine G. DiGiovanna.